RTDR1 inhibitors belong to a chemical class of compounds that specifically target and inhibit the activity of the RTDR1 (Resistant to Desiccation and Radiation 1) protein. RTDR1 is a protein that has been implicated in various biochemical pathways, particularly those related to the cellular stress response. These inhibitors function by binding to the active sites of RTDR1, effectively blocking its enzymatic or regulatory roles in these pathways. By inhibiting RTDR1, these molecules may influence key cellular processes such as oxidative stress management, autophagy, and damage repair mechanisms. The structure of RTDR1 inhibitors typically includes a range of functional groups that allow for selective binding to RTDR1's active domains, often relying on hydrogen bonding, hydrophobic interactions, or even covalent binding in certain cases. This binding can either be reversible or irreversible, depending on the nature of the inhibitor.
The design of RTDR1 inhibitors often involves structural modifications to improve specificity and affinity toward RTDR1, reducing off-target interactions. Computational approaches, such as molecular docking, are frequently used to predict how these inhibitors will interact with RTDR1, guiding further synthetic chemistry efforts. Furthermore, various biophysical methods like X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are employed to elucidate the exact binding conformation of RTDR1 inhibitors within the protein structure. These studies help optimize the inhibitor's efficacy by providing insight into the crucial interaction sites. Understanding the molecular dynamics of RTDR1 and its inhibition offers valuable knowledge about how cells respond to stress, making these inhibitors important tools for studying stress-response pathways at a molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, which could affect gene expression, potentially influencing RTDR1. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor, used in cancer therapy, might affect RTDR1-related pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially altering gene expression profiles, including RTDR1. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Another DNA methyltransferase inhibitor, could influence gene expression patterns. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, could impact signaling pathways, potentially affecting RTDR1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which might indirectly affect proteins involved in cell growth and survival. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Inhibits Wnt/β-catenin signaling, potentially affecting RTDR1-related processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits autophagy and lysosomal degradation, potentially affecting protein turnover related to RTDR1. | ||||||